Literature DB >> 26071922

Outcomes in twin pregnancies reduced to singleton pregnancies compared with ongoing twin pregnancies.

Simi Gupta1, Nathan S Fox2, Jessica Feinberg3, Chad K Klauser2, Andrei Rebarber2.   

Abstract

OBJECTIVE: Multifetal pregnancy reduction has been shown to improve outcomes in triplet and higher-order multiple pregnancies. The data for fetal reduction of twin pregnancies are limited. The purpose of this study was to compare adverse pregnancy outcomes in ongoing twin pregnancies compared with twin pregnancies reduced to singletons. STUDY
DESIGN: This was a retrospective cohort study comparing dichorionic diamniotic twin pregnancies with dichorionic diamniotic twin pregnancies reduced to singleton gestations between 11 and 24 weeks' gestation in a single maternal-fetal medicine practice over a 9 year period. Adverse pregnancy outcomes after 24 weeks were compared, with a value of P < .05 used for significance.
RESULTS: Five hundred one ongoing twin pregnancies and 63 twin pregnancies reduced to singletons were included. Patients with reductions to singletons had a significantly lower risk of preterm delivery before 37 weeks' gestation (10% vs 43%; P < .001) but no difference in the risk of preterm delivery before 34 weeks' or 28 weeks' gestation. Patients with reductions to singletons also had a lower risk of infant birthweight less than the 10% (23% vs 49%; P < .001) but no difference in the risk of infant birthweight less than the 5%. There was no difference in the risk of fetal demise after 24 weeks' gestation.
CONCLUSION: Fetal reduction of twin pregnancies decreases the risk of late preterm birth and birthweight less than the 10% but not the risks of more severe complications such as early preterm birth or birthweight less than the 5%.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  multifetal pregnancy reduction; selective reduction; twin pregnancy

Mesh:

Year:  2015        PMID: 26071922     DOI: 10.1016/j.ajog.2015.06.018

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Is vanishing twin syndrome associated with adverse obstetric outcomes of ART singletons? A systematic review and meta-analysis.

Authors:  Yi-Xin Li; Tian-Ze Sun; Mo-Qi Lv; Liang Zhou; Pan Ge; Hao-Nan Li; Dang-Xia Zhou
Journal:  J Assist Reprod Genet       Date:  2020-08-25       Impact factor: 3.412

2.  Fetal Reduction Could Improve but Not Completely Reverse the Pregnancy Outcomes of Multiple Pregnancies: Experience From a Single Center.

Authors:  Zhu Yimin; Tang Minyue; Fu Yanling; Yan Huanmiao; Sun Saijun; Li Qingfang; Hu Xiaoling; Xing Lanfeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-24       Impact factor: 6.055

3.  Preliminary RNA-Seq Analysis of Long Non-Coding RNAs Expressed in Human Term Placenta.

Authors:  Marta Majewska; Aleksandra Lipka; Lukasz Paukszto; Jan Pawel Jastrzebski; Marek Gowkielewicz; Marcin Jozwik; Mariusz Krzysztof Majewski
Journal:  Int J Mol Sci       Date:  2018-06-27       Impact factor: 5.923

4.  Pregnancy outcome following fetal reduction from dichorionic twins to singleton gestation.

Authors:  Gal Greenberg; Ron Bardin; Shir Danieli-Gruber; Kinneret Tenenbaum-Gavish; Anat Shmueli; Eyal Krispin; Galia Oron; Arnon Wiznitzer; Eran Hadar
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-03       Impact factor: 3.007

5.  Maternal and child-health outcomes in pregnancies following Assisted Reproductive Technology (ART): a prospective cohort study.

Authors:  Shana Ginar da Silva; Mariângela Freitas da Silveira; Andréa Dâmaso Bertoldi; Marlos Rodrigues Domingues; Iná da Silva Dos Santos
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-21       Impact factor: 3.007

6.  Perinatal outcomes in dichorionic diamniotic twins with multifetal pregnancy reduction versus expectant management: A systematic review and meta-analysis.

Authors:  Bihui Jin; Qiongxiao Huang; Mengxia Ji; Zhizhi Yu; Jing Shu
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.